<?xml version="1.0" encoding="UTF-8"?>
<ref id="BST-47-1757C92">
 <label>92</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Shi</surname>
    <given-names>Y.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lim</surname>
    <given-names>S.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liang</surname>
    <given-names>Q.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Iyer</surname>
    <given-names>S.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>H.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>Z.</given-names>
   </name>
   <etal>et al.</etal>
  </person-group> (
  <year>2019</year>) 
  <article-title>Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma</article-title>. 
  <source>Nature</source>
  <volume>567</volume>, 
  <fpage>341</fpage>â€“
  <lpage>346</lpage>
  <pub-id pub-id-type="doi">10.1038/s41586-019-0993-x</pub-id>
  <pub-id pub-id-type="pmid">30842654</pub-id>
 </mixed-citation>
</ref>
